169 related articles for article (PubMed ID: 31799666)
1. PPARγ inhibits breast cancer progression by upregulating PTPRF expression.
Xu YY; Liu H; Su L; Xu N; Xu DH; Liu HY; Spaner D; Bed-David Y; Li YJ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9965-9977. PubMed ID: 31799666
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
[TBL] [Abstract][Full Text] [Related]
3. miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.
Ye X; Qiu R; He X; Hu Z; Zheng F; Huang X; Xie X; Chen F; Ou H; Lin G
Bioengineered; 2022 Jan; 13(1):1090-1102. PubMed ID: 34969357
[TBL] [Abstract][Full Text] [Related]
4. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
Bera R; Chiou CY; Yu MC; Peng JM; He CR; Hsu CY; Huang HL; Ho UY; Lin SM; Lin YJ; Hsieh SY
Hepatology; 2014 Jun; 59(6):2238-50. PubMed ID: 24470239
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
Gan T; Stevens AT; Xiong X; Wen YA; Farmer TN; Li AT; Stevens PD; Golshani S; Weiss HL; Evers BM; Gao T
Oncogene; 2020 Oct; 39(44):6789-6801. PubMed ID: 32973331
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
[TBL] [Abstract][Full Text] [Related]
8. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
Xinxin H; Meng Z; Guiyu Z
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
10. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
Pon CK; Firth SM; Baxter RC
Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421
[TBL] [Abstract][Full Text] [Related]
11. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.
Bonofiglio D; Aquila S; Catalano S; Gabriele S; Belmonte M; Middea E; Qi H; Morelli C; Gentile M; Maggiolini M; Andò S
Mol Endocrinol; 2006 Dec; 20(12):3083-92. PubMed ID: 16887883
[TBL] [Abstract][Full Text] [Related]
13. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
[TBL] [Abstract][Full Text] [Related]
14. PPARγ maintains ERBB2-positive breast cancer stem cells.
Wang X; Sun Y; Wong J; Conklin DS
Oncogene; 2013 Dec; 32(49):5512-21. PubMed ID: 23770845
[TBL] [Abstract][Full Text] [Related]
15. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.
Sun PH; Ye L; Mason MD; Jiang WG
PLoS One; 2012; 7(11):e50183. PubMed ID: 23185569
[TBL] [Abstract][Full Text] [Related]
17. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
[TBL] [Abstract][Full Text] [Related]
18. Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
Fan P; Abderrahman B; Chai TS; Yerrum S; Jordan VC
Mol Cancer Ther; 2018 Dec; 17(12):2732-2745. PubMed ID: 30224430
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.
Whitmore TE; Peterson A; Holzman T; Eastham A; Amon L; McIntosh M; Ozinsky A; Nelson PS; Martin DB
J Proteome Res; 2012 May; 11(5):2653-65. PubMed ID: 22494190
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Qi H; Belmonte M; Catalano S; Andò S
Breast Cancer Res Treat; 2009 Feb; 113(3):423-34. PubMed ID: 18293083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
